Microenvironmental factors like special AT-rich sequence-binding protein 1, prostaglandin E2 and cyclooxygenase 2 can modulate the differentiation of dendritic cells in the TME into a tumor-tolerant phenotype [59,60]. This evidence concerns the gene PTGS2 and neoplasm.